Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Grünig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602425. doi: 10.1183/13993003.02425-2016. Print 2017 Sep.


Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.

Halank M, Hoeper MM, Ghofrani HA, Meyer FJ, Stähler G, Behr J, Ewert R, Fletcher M, Colorado P, Nikkho S, Grimminger F.

Respir Med. 2017 Jul;128:50-56. doi: 10.1016/j.rmed.2017.05.008. Epub 2017 May 16.


Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial.

Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Jansa P, Kim NH, Mayer E, Pulido T, Wang C, Colorado P, Fritsch A, Meier C, Nikkho S, Hoeper MM.

Lancet Respir Med. 2016 May;4(5):372-80. doi: 10.1016/S2213-2600(16)30022-4. Epub 2016 Apr 8.


Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).

Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, Kim NH, Wang C, Wilkins MR, Fritsch A, Davie N, Colorado P, Mayer E.

Eur Respir J. 2015 May;45(5):1293-302. doi: 10.1183/09031936.00087114. Epub 2014 Nov 13.


CFD simulation of mechanical draft tube mixing in anaerobic digester tanks.

Meroney RN, Colorado PE.

Water Res. 2009 Mar;43(4):1040-50. doi: 10.1016/j.watres.2008.11.035. Epub 2008 Dec 6.


Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor.

Nyberg P, Xie L, Sugimoto H, Colorado P, Sund M, Holthaus K, Sudhakar A, Salo T, Kalluri R.

Exp Cell Res. 2008 Nov 1;314(18):3292-305. doi: 10.1016/j.yexcr.2008.08.011. Epub 2008 Aug 26.


Liver abscess and diarrhea as initial manifestations of ulcerative colitis: case report and review of the literature.

Song J, Swekla M, Colorado P, Reddy R, Hoffmann S, Fine S.

Dig Dis Sci. 2003 Feb;48(2):417-21. Review. No abstract available.


Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.

Zeisberg M, Bonner G, Maeshima Y, Colorado P, Müller GA, Strutz F, Kalluri R.

Am J Pathol. 2001 Oct;159(4):1313-21.


Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.

Maeshima Y, Colorado PC, Kalluri R.

J Biol Chem. 2000 Aug 4;275(31):23745-50.


Anti-angiogenic cues from vascular basement membrane collagen.

Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R.

Cancer Res. 2000 May 1;60(9):2520-6.


Distinct antitumor properties of a type IV collagen domain derived from basement membrane.

Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R.

J Biol Chem. 2000 Jul 14;275(28):21340-8.


Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth.

Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R.

J Biol Chem. 2000 Jan 14;275(2):1209-15.


Fire and ice. Natives, alcohol and spirituality, a northern health paradigm.

Colorado P.

Arctic Med Res. 1988;47 Suppl 1:598-603. No abstract available.


Supplemental Content

Loading ...
Support Center